Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.5.0.2
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Research and Development Expense $ 1,153,043 $ 489,563 $ 1,579,157 $ 791,642    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 8,450,190   8,450,190   7,780,190  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares) 7,000,400   7,000,400      
Registration Payment Arrangement, Accrual Carrying Value $ 0   $ 0   $ 0 $ 55,620
Employee Stock Option [Member]            
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 8,450,190   8,450,190   7,780,190  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares) 7,000,400   7,000,400   5,613,501